Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M del Amo

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Experimental Eye Research|February 9, 2018
Corrigendum to "Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published data" [Exp. Eye Res. 137C (2015) 111-124]Eva M Del Amo, Arto Urtti
Experimental Eye Research|May 16, 2015
Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published dataEva M Del Amo, Arto Urtti
Drug Discovery Today|February 16, 2008
Current and future ophthalmic drug delivery systems. A shift to the posterior segmentEva M Del Amo, Arto Urtti
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 29, 2008
Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2Eva M del Amo, Arto Urtti, Marjo Yliperttula
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 2008
In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorptionEva M del Amo, Aki T Heikkinen, Jukka Mönkkönen
The Journal of Pharmacology and Experimental Therapeutics|November 11, 2022
Comments on <i>"Ocular Pharmacokinetics of Brimonidine Drug Delivery System in Monkeys and Translational Modeling for Selection of Dose and Frequency in Clinical Trials</i>"Eva M Del Amo, Arto Urtti, Veli-Pekka Ranta
AJNR. American Journal of Neuroradiology|June 1, 1996
MR in trichloroethane poisoningM del Amo, J Berenguer, T Pujol, et al.
Investigative Ophthalmology & Visual Science|September 17, 2024
Mathematical Models of Ocular Drug DeliveryAmir Sadeghi, Astrid Subrizi, Eva M Del Amo, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 13, 2023
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degenerationEva M Del Amo, Paul N Bishop, Pere Godia, et al.
Pharmaceutical Research|July 11, 2012
Prediction of the vitreal half-life of small molecular drug-like compoundsHeidi Kidron, Eva M Del Amo, Kati-Sisko Vellonen, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Experimental Eye Research|February 9, 2018
Corrigendum to "Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published data" [Exp. Eye Res. 137C (2015) 111-124]Eva M Del Amo, Arto Urtti
Experimental Eye Research|May 16, 2015
Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published dataEva M Del Amo, Arto Urtti
Drug Discovery Today|February 16, 2008
Current and future ophthalmic drug delivery systems. A shift to the posterior segmentEva M Del Amo, Arto Urtti
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 29, 2008
Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2Eva M del Amo, Arto Urtti, Marjo Yliperttula
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 2008
In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorptionEva M del Amo, Aki T Heikkinen, Jukka Mönkkönen
The Journal of Pharmacology and Experimental Therapeutics|November 11, 2022
Comments on <i>"Ocular Pharmacokinetics of Brimonidine Drug Delivery System in Monkeys and Translational Modeling for Selection of Dose and Frequency in Clinical Trials</i>"Eva M Del Amo, Arto Urtti, Veli-Pekka Ranta
AJNR. American Journal of Neuroradiology|June 1, 1996
MR in trichloroethane poisoningM del Amo, J Berenguer, T Pujol, et al.
Investigative Ophthalmology & Visual Science|September 17, 2024
Mathematical Models of Ocular Drug DeliveryAmir Sadeghi, Astrid Subrizi, Eva M Del Amo, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 13, 2023
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degenerationEva M Del Amo, Paul N Bishop, Pere Godia, et al.
Pharmaceutical Research|July 11, 2012
Prediction of the vitreal half-life of small molecular drug-like compoundsHeidi Kidron, Eva M Del Amo, Kati-Sisko Vellonen, et al.
Pageof 6